In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
At Hospital/Institution:  Presbyterian - St. Luke's Medical Center
Keywords/Phrases:  leukemia
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2239.00, NCI-2009-01551, P30CA015704, FHCRC-2239.00, 6722, FHCRC-IR-6722, NCT00723099

2.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575

3.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000357586, ECOG-E3903, E3903, NCT00897767

4.

Phase: No phase specified
Type: Health services research, Tissue collection/Repository
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: AALL08B1, NCI-2011-02235, CDR0000674844, COG-AALL08B1, U10CA098543, NCT01142427

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AALL1131, NCI-2011-03797, CDR0000706370, U10CA098543, COG-AALL1131, NCT01406756

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: NCI-2011-02670, COG-AAML1031, CDR0000701850, AAML1031, U10CA098543, NCT01371981

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI CLL 18, NCT01848145

8.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02621, CDR0000690286, CALGB-10701, CALGB 10701/CTSU C10701, U10CA031946, P30CA014236, NCT01256398

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000659585, ECOG-E2906, E2906, NCT01041703

12.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Under 31
Sponsor: NCI, Other
Protocol IDs: CDR0000491159, COG-AALL05B1, AALL05B1, NCT00897325

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2014-00118, ECOG-E1912, E1912, U10CA021115, U10CA180820, NCT02048813

14.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, CDR0000514500, COG-AALL0434, AALL0434, U10CA098543, NCT00408005

15.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ANHL1131, NCI-2012-01963, CDR0000732604, U10CA098543, COG-ANHL1131, NCT01595048

16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P30CA015704, P01CA018029, NCT01231412

17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2010LSUC043, MT2010-06, P01CA111412, NCT01288222

18.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 0 months to 30 year
Sponsor: NCI, Other
Protocol IDs: ABTR01B1, NCI-2009-00324, CDR0000271415, COG-ABTR01B1, U10CA098543, NCT00898079

19.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ALTE05N1, NCI-2009-00382, CDR0000590123, U10CA098543, COG-ALTE05N1, NCT00736749

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0610-01, NCT01949883

21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01173, CDR0000634119, U10CA021115, ECOG-E2905, E2905, U10CA180820, NCT00843882

22.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000588879, CALGB-30610, RTOG 0538, U10CA031946, NCT00632853

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000667496, CALGB-30901, NCT01085630

24.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000675693, CALGB-80702, CALGB-SWOG-C80702, NCT01150045

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Under 90 days at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000636115, COG-AAML08B1, AAML08B1, NCT00959283
1   
New Search